Strs Ohio Sells 1,000 Shares of PetIQ, Inc. (NASDAQ:PETQ)

Strs Ohio trimmed its holdings in PetIQ, Inc. (NASDAQ:PETQ) by 3.0% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 31,900 shares of the company’s stock after selling 1,000 shares during the quarter. Strs Ohio owned about 0.11% of PetIQ worth $630,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the business. DekaBank Deutsche Girozentrale bought a new stake in PetIQ in the 4th quarter worth about $50,000. China Universal Asset Management Co. Ltd. boosted its position in PetIQ by 351.4% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 3,372 shares of the company’s stock worth $67,000 after purchasing an additional 2,625 shares during the last quarter. Raymond James & Associates purchased a new position in PetIQ in the fourth quarter worth about $209,000. SG Americas Securities LLC boosted its position in PetIQ by 75.1% in the fourth quarter. SG Americas Securities LLC now owns 10,054 shares of the company’s stock worth $199,000 after purchasing an additional 4,311 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in PetIQ by 13.4% in the third quarter. Vanguard Group Inc. now owns 1,918,500 shares of the company’s stock worth $37,794,000 after purchasing an additional 226,718 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors.

PetIQ Stock Up 1.3 %

PETQ stock opened at $16.53 on Friday. PetIQ, Inc. has a twelve month low of $11.26 and a twelve month high of $22.98. The company has a quick ratio of 1.43, a current ratio of 2.27 and a debt-to-equity ratio of 1.97. The stock has a market cap of $486.48 million, a P/E ratio of 275.55 and a beta of 1.64. The business’s 50-day moving average price is $17.30 and its 200-day moving average price is $18.25.

PetIQ (NASDAQ:PETQ) last posted its quarterly earnings data on Wednesday, February 28th. The company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.38) by $0.22. PetIQ had a return on equity of 11.72% and a net margin of 0.19%. The firm had revenue of $219.93 million for the quarter, compared to analysts’ expectations of $189.70 million. On average, equities research analysts forecast that PetIQ, Inc. will post 0.94 EPS for the current year.

Analyst Ratings Changes

Separately, Jefferies Financial Group raised their target price on PetIQ from $24.00 to $28.00 and gave the stock a “buy” rating in a research report on Tuesday, March 19th. Four research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $29.00.

About PetIQ

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.